egtazic acid has been researched along with Liver Steatosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CT; Cheng, JT; Chi, CW; Chung, HH; Wu, HT; Yang, PS; Yeh, CH | 1 |
| Bahou, WF; Chiariello, CS; LaComb, JF; Schmidt, VA | 1 |
2 other study(ies) available for egtazic acid and Liver Steatosis
| Article | Year |
|---|---|
Rilmenidine improves hepatic steatosis through p38-dependent pathway to higher the expression of farnesoid X receptor.
Topics: Animals; Calcium; Cell Line, Tumor; Diet, High-Fat; Egtazic Acid; Fatty Liver; Humans; Imidazoline Receptors; Lipid Metabolism; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Oleic Acid; Oxazoles; Receptors, Cytoplasmic and Nuclear; Rilmenidine | 2012 |
Ablation of Iqgap2 protects from diet-induced hepatic steatosis due to impaired fatty acid uptake.
Topics: Animals; Cells, Cultured; Chelating Agents; Diet, High-Fat; Egtazic Acid; Fatty Acid Synthases; Fatty Acids, Nonesterified; Fatty Liver; Gene Expression Profiling; Glucose Tolerance Test; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Liver; Male; Mice; Mice, 129 Strain; Mice, Knockout; PPAR alpha; ras GTPase-Activating Proteins; Transcription, Genetic; Triglycerides; Weight Gain | 2012 |